All filters
Abstracts
A Hybrid Interpersonal Training Model to build Capacity for Health-Care-Providers (HITCH) to Manage Children, Adolescents and Adults on Third-Line Anti-Retro Viral (ART) Therapy in Uganda.
E. Magongo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
J. van Wyk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Optimizing HIV Treatment among Children in Mozambique
M. Tomo De Deus
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Impact of community resource persons and mobile phone technology on return to HIV care among loss to follow up HIV clients in 104 HIV facilities in Uganda
A. Mugisa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
U=U - Catalyst or Barrier for Men's Engagement in ART? Stakeholder Views from Blantyre, Malawi
A. Berner-Rodoreda
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Patient-reported reasons for missed appointments among ART patients in South Africa
C. Biedron
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Evaluation of Second Line Antiretroviral Programmatic and Treatment Outcomes in Mozambique between 2015-2017
A. Muteerwa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
"You are not benefiting us by keeping us away": Why do some eligible people on antiretroviral therapy (ART) decline to participate in Ethiopia's appointment spacing model with 6-month ART dispensing?
J. Mantell
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Minimal cross-resistance to tenofovir in children and adolescents failing abacavir-based ART makes them eligible for tenofovir-lamivudine-dolutegravir treatment.
K. Steegen
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Factors associated with unsuppressed viral load among patients enrolled in the Community HIV Care Program in Botswana. A retrospective cross-sectional study.
C. Trapence
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving retention in ART care using Call-2Care© approach: A snapshot from Defence Forces of Zambia (DFZ)
P. Makelele
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The effect of home-based care in achieving viral load coverage in two high volume facilities in Akwa Ibom state, Nigeria
O. Toyo
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving linkage to antiretroviral therapy using a peer attachment model in selected facilities in the Southern Highland Zone of Tanzania
A. Ngwalle
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Acceptability of Quadrimune, a new Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed dose combination
V. Musiime
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Limited increase in primary HIV‐1C drug resistance mutations in treatment naïve individuals in Ethiopia
K. Ghezehegn
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Comparative study on the liver profile of HIV positive pregnant women and HIV positive non-pregnant women attending the Bamenda Regional Hospital, Cameroon
M. Alice Enekegbe
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Virological suppression among HIV infected adolescents and youths receiving ART in the National teaching and referral hospital in Kenya.
J. Kangethe
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
HIV-1C proviral DNA for detection of drug resistance mutations
K. Ghezehegn
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Durability of Second-line Anti-Retroviral Therapy and Predictors of a Viral Rebound Among HIV Patients on Second-line ART in an HIV Specialist Clinic in Uganda: A 10-Year Retrospective Cohort
I. Lumu
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Zimbabwe’s National Third-Line Antiretroviral Therapy Program: Cohort Description and Treatment Outcomes
C. Chimbetete
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Low Baseline-Resistance to Integrase Inhibitors in Cameroon: Implications in the Era of Dolutegravir-based Regimens in Sub-Saharan Africa
E. Ngoufack Jagni Semengue
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
In Urban settings, Vertically-Infected Adolescents Experience Treatment Failure driven by HIV Drug Resistance Emergence: Results from a Follow-up Analysis in Cameroon
D. Njume
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Where are the men in Gaza? A cross-sectional study to understand the residency patterns of male partners of women accessing HIV services in Gaza, Mozambique
S. Ndima
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Accurate HIV Viral Load in Primary Healthcare Centers using Plasma Separation Cards
A. Vubil
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020